Solana Tokens Held Increased During the Quarter by ~189,000 or 9% (35% Annualized)
Digital Asset Revenue Totaled $3.5 Million for the Quarter
Conference Call Scheduled for Today, May 12, 2026, at
“This quarter’s results reflect diligently executing against our digital asset treasury strategy of accumulating SOL on an accretive per-share basis and maintaining a flexible capital structure that positions us to pursue opportunities as they emerge,” said
Financial Highlights for the Quarter Ended
- Total revenue for the quarter was approximately
$4.6 million , compared to$3.2 million for the same quarter endedMarch 31, 2025 . - Gross profit totaled
$4.4 million , up 179% year-over-year, due to the addition of the digital asset treasury business. - Net loss totaled
$109.3 million , or$1.67 per share, compared to a net loss of$3.8 million , or$2.87 per share, for the quarter endedMarch 31, 2025 . This net loss was largely driven by$92.3 million of unrealized losses on digital assets, reflecting non-cash quarter-end fair value adjustments. - Cash and cash equivalents increased to
$3.5 million as ofMarch 31, 2026 . - Reduced short term debt by approximately
$7.6 million , including approximately$5.4 million in short term treasury debt.
Operational and Other Highlights During and Subsequent to the Quarter
- In the nine months ended
March 31, 2026 , the Company repurchased and retired 2,894,287 shares ofUpexi common stock under the current repurchase program. - Completed
$36 million private placement convertible note in exchange for 265,500 locked Solana tokens. - Completed
$7.4 million registered direct offering. - Reduced ongoing operational costs, including the reduction of the employee count to 10 employees, the elimination of a warehouse lease and the elimination of several other general and administrative costs.
- Management estimates that by
July 1, 2026 , the ongoing cash expenses for operations and interest will be less than the treasury’s staking revenue at the current price of Solana.
The Company’s Quarterly Report on Form 10-Q for this period is available on the SEC’s website and on Upexi’s IR website.
| Conference Call Information | |
| Event: | Fiscal Third Quarter 2026 Earnings Call |
| Date: | |
| Time: | |
| Live Call: | 1-877-407-9716 ( |
| Webcast: | https://ir.upexi.com/news-events/ir-calendar |
For interested individuals unable to join the conference call, a dial-in replay of the call will be available until
About
Follow
Follow CEO,
Follow CSO,
Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. For example, the Company is using forward looking statements when it discusses the anticipated use of proceeds. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with business strategy, potential acquisitions, revenue guidance, product development, integration, and synergies of acquiring companies and personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward- looking statements. Although we believe that the beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Company Contact
Email: brian.rudick@upexi.com
Phone: (203) 442-5391
Investor Contact
Upexi@KCSA.com
| CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) | ||||||||
| 2026 | 2025 | |||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash | $ | 3,482,847 | $ | 2,975,150 | ||||
| Accounts receivable, net | 496,393 | 157,515 | ||||||
| Inventory, net | 215,237 | 1,152,870 | ||||||
| Due from VitaMedica transition | 336,239 | 228,017 | ||||||
| Prepaid expenses and other receivables | 990,957 | 350,836 | ||||||
| Current digital assets at fair value | 114,942,784 | 49,913,655 | ||||||
| Purchase price receivable - VitaMedica | 1,340,000 | 2,000,000 | ||||||
| Total current assets | 121,804,457 | 56,778,043 | ||||||
| Property and equipment, net | 241,215 | 2,052,573 | ||||||
| Intangible assets, net | 855,543 | 163,113 | ||||||
| 673,854 | 848,854 | |||||||
| Deferred tax asset | 5,948,858 | 5,948,858 | ||||||
| Digital assets at fair value, net of current | 69,960,104 | 56,083,525 | ||||||
| Other assets | 178,589 | 192,123 | ||||||
| Right-of-use asset, net | 711,063 | 1,739,755 | ||||||
| Total noncurrent assets | 78,569,226 | 67,028,801 | ||||||
| Total assets | $ | 200,373,683 | $ | 123,806,844 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ | 288,722 | $ | 1,039,370 | ||||
| Accrued compensation | 4,506,613 | 3,470,296 | ||||||
| Deferred revenue | 2,324 | 13,155 | ||||||
| Accrued liabilities | 2,166,822 | 356,064 | ||||||
| Accrued interest | 2,268,473 | 792,449 | ||||||
| Acquisition payable | 260,652 | 260,652 | ||||||
| Current portion of promissory notes | - | 560,000 | ||||||
| Short-term treasury debt | 57,295,723 | 20,000,000 | ||||||
| Current portion of Cygnet subsidiary notes payable | 3,694,721 | 5,380,910 | ||||||
| Current portion of operating lease payable | 339,669 | 691,010 | ||||||
| Total current liabilities | 70,823,719 | 32,563,906 | ||||||
| Operating lease payable, net of current portion | 437,077 | 1,145,440 | ||||||
| Convertible notes payable | 181,031,073 | - | ||||||
| Total long-term liabilities | 181,468,150 | 1,145,440 | ||||||
| Stockholders' equity | ||||||||
| Preferred stock, | 2 | 2 | ||||||
| Common stock, | 669 | 383 | ||||||
| Additional paid in capital | 230,145,603 | 150,640,935 | ||||||
| Accumulated deficit | (282,064,460 | ) | (60,543,822 | ) | ||||
| Total stockholders' equity | (51,918,186 | ) | 90,097,498 | |||||
| Total liabilities and stockholders' equity | $ | 200,373,683 | $ | 123,806,844 | ||||
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | ||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Revenue | ||||||||||||||||
| Revenue | $ | 1,050,667 | $ | 3,160,480 | $ | 7,115,322 | $ | 11,522,487 | ||||||||
| Digital asset revenue | 3,506,432 | - | 14,733,562 | - | ||||||||||||
| Total revenue | 4,557,099 | 3,160,480 | 21,848,884 | 11,522,487 | ||||||||||||
| Cost of revenue | 206,365 | 1,601,374 | 2,503,991 | 4,059,207 | ||||||||||||
| Gross profit | 4,350,734 | 1,559,106 | 19,344,893 | 7,463,280 | ||||||||||||
| Operating expenses | ||||||||||||||||
| Sales and marketing | 553,300 | 1,039,299 | 2,536,696 | 3,030,687 | ||||||||||||
| Distribution costs | 588,652 | 990,049 | 2,400,449 | 3,722,196 | ||||||||||||
| General and administrative | 4,931,678 | 2,642,654 | 19,711,672 | 5,558,934 | ||||||||||||
| Unrealized loss on digital assets | 92,307,488 | 5,268 | 178,806,383 | 5,268 | ||||||||||||
| Realized loss on digital asset revenue conversion to USD | 1,887,472 | - | 2,229,071 | - | ||||||||||||
| Realized loss on sale of digital assets | 6,773,418 | - | 6,773,418 | - | ||||||||||||
| Stock-based compensation | 3,987,514 | 521,353 | 18,044,585 | 695,229 | ||||||||||||
| Amortization of acquired intangible assets | 19,190 | 19,191 | 57,570 | 57,571 | ||||||||||||
| Impairment on assets from manufacturing shut down | - | - | 1,422,289 | - | ||||||||||||
| Depreciation | 88,289 | 198,519 | 358,579 | 658,986 | ||||||||||||
| Lease Impairment (gain on settlement) | - | (269,994 | ) | - | (269,994 | ) | ||||||||||
| 111,137,001 | 5,146,339 | 232,340,712 | 13,458,877 | |||||||||||||
| Loss from operations | (106,786,267 | ) | (3,587,233 | ) | (212,995,819 | ) | (5,995,597 | ) | ||||||||
| Other expense, net | ||||||||||||||||
| Interest expense, net | (3,683,334 | ) | (245,103 | ) | (9,987,426 | ) | (763,626 | ) | ||||||||
| Other income, net | 1,125,771 | 676 | 1,462,607 | 676 | ||||||||||||
| Other expense, net | (2,557,563 | ) | (244,427 | ) | (8,524,819 | ) | (762,950 | ) | ||||||||
| Loss on operations before income tax | (109,343,830 | ) | (3,831,660 | ) | (221,520,638 | ) | (6,758,547 | ) | ||||||||
| Income tax benefit (expense) | - | - | - | - | ||||||||||||
| Net loss | $ | (109,343,830 | ) | $ | (3,831,660 | ) | $ | (221,520,638 | ) | $ | (6,758,547 | ) | ||||
| Basic loss per share: | ||||||||||||||||
| Loss per share | $ | (1.67 | ) | $ | (2.87 | ) | $ | (3.66 | ) | $ | (5.92 | ) | ||||
| Diluted loss per share: | ||||||||||||||||
| Loss per share | $ | (1.67 | ) | $ | (2.87 | ) | $ | (3.66 | ) | $ | (5.92 | ) | ||||
| Basic weighted average shares outstanding | 65,506,837 | 1,336,373 | 60,522,907 | 1,140,995 | ||||||||||||
| Fully diluted weighted average shares outstanding | 65,506,837 | 1,336,373 | 60,522,907 | 1,140,995 | ||||||||||||
Source: